Aristotle University Of Thessaloniki (AUTH)
Μοριακή έρευνα και επιδημιολογική συσχέτιση στελεχών ψευδομονάδων που παράγουν μεταλλο-β-λακταμάσες
Abstract
dc:description160 different species of the large Pseudomonas genus have been described but Clinical Microbiology is only interested in some of them either as natural habitats of the human body, as co-causers of infections or as plain pathogens. P. aeruginosa has long been studied by scientists as a cause of serious infections. It is an opportunistic pathogen which causes infections mostly to immunocompromised patients and is reported to be one of the most common cause of hospital acquired infections. Imipenem and meropenem are b- lactams which belong to carbapenems and are used for the treatment of infections caused by P. aeruginosa either as monotherapy or in combination to other drugs with anti-pseudomonal action. The development of bacterial resistance is a serious threat to the favourable outcome of common infections in community and hospital settings. Bacterial resistance is the result of the development and dissemination of acquired mechanisms of resistance. Mechanisms of resistance which confer acquired resistance of P. aeruginosa to b-lactams, aminoglycosides and polymyxines are: i) enzymatic degradation or modification of the antimicrobial agent, ii) reduced impermeability of the outer membrane, iii) upregulation of efflux pumps, iv) altered targets of antibiotic action. The production of metallo-b-lactamases belongs to the first category, the enzymatic degradation. Metallo-b-lactamases are classified into 5 subgroups which are named IMP, VIM, SPM, GIM and SIM. SPM, GIM and SIM include only one type of enzyme and have been described in America, Germany and Korea respectively. In contrast, VIM and IMP include 22 and 24 enzymes respectively and present worldwide dissemination. Metallo-b-lactamases consist of the most novel mechanism of resistance to imipenem and meropenem. The aim of this thesis was: a) the molecular investigation of metallo-blactamases as an acquired mechanism of resistance to imipenem and meropenem in P. aeruginosa isolates, b) the molecular detection of dissemination of P. aeruginosa isolates with metallo-b-lactamase gene in the nosocomial setting, c) the determination of risk factors for the development of these isolates. For these purposes, a total of 361 clinical isolates of P. aeruginosa were isolated from cultures of specimens collected from hospital patients, personnel and hospital environment. The 106 isolates resistant to imipenem and meropenem (29,3%) were phenotypically tested for the production of metallo-b-lactamase. 35,8% of the resistant strains were positive for the metalloenzyme. All isolates were also tested for their resistance to other antimicrobial agents used for P. aeruginosa. A statistically important difference was observed in resistance to antibiotics between carbapenem resistant and sensitive strains. Specifically, antibiotic resistance between carbapenem resistant and sensitive strains was: Piperacillin (63,2% vs 9,8%), Piperacillin/Tazobactam (34,9% vs 5%), Ceftazidime (74,5% vs 14,9%), Cefepime (72,6% vs 9,4%), Aztreonam (54,7% vs 17,2%), Gentamycin (54,7% vs 14,5%), Amikacin (59,4% vs 10,1%), Tobramycin (66,9% vs 7,8%), Netilmycin (55,6% vs 9,8%), Ciprofloxacin (80,1% to 13,3%), Norfloxacin (82% vs 17,6%), Colistin (8,4% vs 3,5%). Carbapenem resistrant strains were always multidrug resistant. Real-Time PCR and a new protocol was performed based on the needs of this study and thus blaVIM gene was detected in 38 out of 106 isolates of P. aeruginosa resistant to carbapenems (35,8%). This protocol provides the advantage of testing 15 out of 22 blaVIM and 11 out of 24 blaIMP genes in one reaction. Using the DNA Sequencing method it was revealed that in 32 out of 38 isolates blaVIM gene was part of the variable region of the integron class 1. In 28 out of 32 isolates, blaVIM-2 gene co-existed in the variable region of the integron area with an aminoglycoside resistant gene. Integrons are often found in transposons. Transposons are DNA parts having the ability to move from plasmid to plasmid, from plasmid to a phage or from a plasmid to a chromosome with the aid of an enzyme named transposase which is coded by the transposon. Using palse field gel electrophoresis (PFGE), DNA analysis of the isolates which carried the blaVIM gene was performed and the comparison of their electrophoretic profiles showed that four epidemic clones existed with dissemination to different parts and intensive care units of the hospital. Statistical analysis of the patients’ epidemiological data using x² test (Chi-square test) or Fisher’s exact test when the expected frequency number was low (<5), showed that risk factors exist, such as treatment in the intensive care unit, intubation, installation of urocatheters, rhinogastric catheterization, administration of corticosteroids. The presence of these risk factors is crucial for the development of P. aeruginosa strains resistant to carbapenems. Finally, statistical analysis revealed that patient mortality is statistically significantly relevant to infections caused by pseudomonas spp resistant to carbapenems Data produced out of this thesis can significantly contribute to the confrontation of dissemination of the resistant strains and to the reasonable use of carbapenemases in order to retain the efficacy of the drugs.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bisiklis, Alexandros
- Μπισικλής, Αλέξανδρος
Subjects
dc:subject × 22- Ψευδομονάδα πυοκυανίκη
- Μέταλλο-Β-λακταμάσες
- Γονίδια αντοχής
- Αντιμικροβιακή αντοχή
- Αλυσιδωτή αντίδραση πολυμεράσης
- Μοριακή επιδημιολογία
- Καρβαπενέμες
- Ιμιπενέμη
- Μεροπενέμη
- Pseudomonas aeruginosa
- Metallo-beta-lactamases (MBL)
- Resistance genes
- Antimicrobial resistance
- Real time PCR
- Molecular epidemiology
- Carbapenems
- Imipenem
- Meropenem
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19480